Laboratory of Environmental and Metabolic Health Sciences, Center for Disease Biology and Integrative Medicine, Graduate School of Medicine, the University of Tokyo.
Lipid Metabolism Project, Tokyo Metropolitan Institute of Medical Science.
Proc Jpn Acad Ser B Phys Biol Sci. 2017;93(9):677-702. doi: 10.2183/pjab.93.043.
The phospholipase A (PLA) family comprises a group of lipolytic enzymes that typically hydrolyze the sn-2 position of glycerophospholipids to give rise to fatty acids and lysophospholipids. The mammalian genome encodes more than 50 PLAs or related enzymes, which are classified into several subfamilies on the basis of their structures and functions. From a general viewpoint, the PLA family has mainly been implicated in signal transduction, producing bioactive lipid mediators derived from fatty acids and lysophospholipids. Recent evidence indicates that PLAs also contribute to phospholipid remodeling for membrane homeostasis or energy production for fatty acid β-oxidation. Accordingly, PLA enzymes can be regarded as one of the key regulators of the quality of lipids, which I herein refer to as lipoquality. Disturbance of PLA-regulated lipoquality hampers tissue and cellular homeostasis and can be linked to various diseases. Here I overview the current state of understanding of the classification, enzymatic properties, and physiological functions of the PLA family.
磷脂酶 A(PLA)家族包含一组脂肪酶,它们通常在甘油磷脂的 sn-2 位置水解,生成脂肪酸和溶血磷脂。哺乳动物基因组编码了 50 多种 PLA 或相关酶,它们根据结构和功能分为几个亚家族。从一般观点来看,PLA 家族主要参与信号转导,产生源自脂肪酸和溶血磷脂的生物活性脂质介质。最近的证据表明,PLAs 也有助于膜内稳态的磷脂重塑或脂肪酸 β-氧化的能量产生。因此,PLA 酶可以被视为脂质质量的关键调节剂之一,我在此将其称为“脂质量”。PLA 调节的脂质量的紊乱会破坏组织和细胞内稳态,并与各种疾病有关。在这里,我概述了对 PLA 家族的分类、酶特性和生理功能的现有理解。